These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Haemodialysis for renal failure in a case of systemic lupus erythematosus (author's transl)]. Schmidt P, Kopsa H, Zazgornik J. Dtsch Med Wochenschr; 1975 Jun 13; 100(24):1335-7. PubMed ID: 1079489 [Abstract] [Full Text] [Related]
10. Acute renal failure resulting from intravenous immunoglobulin therapy. Wajanaponsan N, Cheng SF. Hawaii Med J; 2004 Sep 13; 63(9):266-7. PubMed ID: 15540524 [Abstract] [Full Text] [Related]
11. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus]. Francioni C, Fioravanti A, Gelli R, Megale F, Marcolongo R. Recenti Prog Med; 1993 Oct 13; 84(10):679-86. PubMed ID: 8235034 [Abstract] [Full Text] [Related]
12. [Acute renal failure following treatment with intravenously administered immunoglobulins]. van Zanten AR, Beekhuyzen M, van der Meer YG, de Gooijer A, Feith GW. Ned Tijdschr Geneeskd; 2003 Feb 15; 147(7):307-10. PubMed ID: 12622009 [Abstract] [Full Text] [Related]
13. Intravenous gammglobulin-associated acute renal failure. Gupta N, Ahmed I, Nissel-Horowitz S, Patel D, Mehrotra B. Am J Hematol; 2001 Feb 15; 66(2):151-2. PubMed ID: 11421298 [Abstract] [Full Text] [Related]
14. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences]. Pirner K, Rubbert A, Burmester GR, Kalden JR, Manger B. Infusionsther Transfusionsmed; 1993 Apr 15; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742 [Abstract] [Full Text] [Related]
15. Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease. Becker BN, Fuchs H, Hakim R. J Am Soc Nephrol; 1995 Apr 15; 5(10):1746-50. PubMed ID: 7787141 [Abstract] [Full Text] [Related]
17. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia. Subtirelu MM, Flynn JT, Schechner RS, Pullman JM, Feuerstein D, Del Rio M. Pediatr Transplant; 2005 Dec 15; 9(6):801-4. PubMed ID: 16269055 [Abstract] [Full Text] [Related]
18. A comparison of continuous renal replacement therapy to intermittent dialysis in the management of renal insufficiency in the acutely III surgical patient. Waldrop J, Ciraulo DL, Milner TP, Gregori D, Kendrick AS, Richart CM, Maxwell RA, Barker DE. Am Surg; 2005 Jan 15; 71(1):36-9. PubMed ID: 15757054 [Abstract] [Full Text] [Related]
19. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation. Chapman SA, Gilkerson KL, Davin TD, Pritzker MR. Ann Pharmacother; 2004 Dec 15; 38(12):2059-67. PubMed ID: 15536143 [Abstract] [Full Text] [Related]
20. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid. Gürcan HM, Ahmed AR. Ann Pharmacother; 2007 Oct 15; 41(10):1604-10. PubMed ID: 17785614 [Abstract] [Full Text] [Related] Page: [Next] [New Search]